Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Peanuts May Improve Arterial Health, Reduce the Risk of Cardiovascular Disease



The researchers found that consuming peanuts helped to lessen the release of lipids into the bloodstream. 

Share this!

April 3, 2017 | by Sarah Hand, M.Sc.

According to researchers at The Pennsylvania State University, peanut consumption at mealtime could help reduce the risk of heart attacks, strokes and other cardiovascular diseases. The researchers published their findings in The Journal of Nutrition.

“Typically, whenever we eat something, it causes the arteries to get a little bit stiffer during the post-meal period, but we have shown that if you eat peanuts with your meal, this can help prevent the stiffening response,” said Penny Kris-Etherton, distinguished professor of nutrition, Penn State. “When the stiffening response happens in the cells that line the arteries, resulting in decreased elasticity in the arteries, it can limit the availability of nitric oxide, and when there's less nitric oxide, the arteries don't dilate that much. What you want is a dilation of the arteries and for them to be really elastic.”

During the study, the researchers gave overweight and obese men approximately three ounces of peanuts to eat along with a high-fat meal. The researchers found that consuming peanuts helped to lessen the release of lipids into the bloodstream.

This spike in blood lipid concentration after consuming a fatty meal has previously been associated with a higher risk of cardiovascular disease. As postprandial arterial stiffening can force the heart muscle to pump harder to pump the blood through the vessels, this phenomenon can also increase the risk of cardiovascular events.

“As the heart works harder and harder, over a long period of time, it could lead, ultimately, to heart failure,” said Kris-Etherton. According to the researchers, peanuts could help the arterial cells retain their elasticity, potentially minimizing the risk of heart attacks and strokes.

“After a meal, triglycerides increase and this typically decreases the dilation of the arteries, but the peanuts prevent that big increase in triglycerides after the meal,” said Kris-Etherton. “And that may be the mechanism behind this effect, because the triglycerides are not getting so high, which may explain why there is not a decrease in artery elasticity.”

Kris-Etherton and her colleagues observed a 32 percent reduction in blood triglyceride levels after the high-fat meals were consumed with peanuts, compared to a control group. The researchers plan to conduct larger studies in the future, involving both men and women, in order to study the potential health benefits of peanuts.

Keywords:  Cardiovascular Disease, Heart Attack, Stroke


Share this with your colleagues!

Samsung Bioepis and Takeda to Co-Develop Novel Biologic Drugs

August 22, 2017 - Biosimilars drugmaker Samsung Bioepis has joined forces with Takeda Pharmaceutical to develop biologic therapies in novel disease areas.

Featured In: Biotech News

Improving Administration of Blood Thinner Drugs through an Online Course for Nurses

August 22, 2017 - Patients’ refusal of blood thinners can influence a nurse’s decision to administer the drugs, but an online educational program could help to address this issue.

Featured In: Life Science News

Exploring the FDA’s Accelerated Approval Pathway

August 21, 2017 - Investigational new drugs that could fill an unmet medical need are sometimes granted “Accelerated Approval” by the US Food and Drug Administration (FDA) in an effort to make these medicines available to the patients who need them.

Featured In: Pharmaceutical News


One Patient’s Perspective on Clinical Trials


Planning and Conducting Trials of the Latest Immunotherapies

ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation

Medical Devices: Reviewing Regulatory Changes in the US and EU

Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials

Copyright © 2016-2017 Honeycomb Worldwide Inc.